Virtual Science
AI-powered intelligence platform for life sciences insights.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | €0.0 | round |
N/A | Seed | ||
| Total Funding | 000k | ||
Virtual Science AI, founded in London in 2021 by Tom Hughes, provides an AI-driven platform for the life sciences and healthcare sectors. The company aims to transform how the healthcare industry generates and analyzes external stakeholder insights.
Founder and CEO Tom Hughes has a background in sales and marketing at Pfizer and served as Global Franchise Lead at Pharmaspectra before establishing Virtual Science AI. His experience in developing SaaS businesses informs the company's vision. The leadership team includes CTO Chih Han (Hans) Chen, who has a background in building AI/ML products, and other executives with experience from companies like Gilead Sciences and Roboyo.
The company's core offering is a medical intelligence platform that turns complex scientific data into actionable insights for life science teams. The platform uses an AI-driven, "Human-in-the-Loop" approach to ensure accuracy and speed in generating insights from interactions with healthcare professionals, patients, and payers. Key products include the Virtual Advisory AI, a virtual engagement platform for advisory boards that provides AI-generated analytics on trends and themes. It also features an intelligent Q&A search function that delivers real-time answers to strategic questions about disease areas and treatments. The services are designed for various functions within pharmaceutical companies, including R&D, medical affairs, and commercial teams, and are used by 12 of the top 20 pharmaceutical companies.
Virtual Science AI operates on a software-as-a-service (SaaS) business model. The company has secured $1.13 million in a seed funding round and is backed by investors including Haatch and Triple Point.
Keywords: medical intelligence, life sciences, AI platform, stakeholder engagement, healthcare insights, pharmaceutical analytics, SaaS, advisory boards, scientific data analysis, Tom Hughes, real-time insights, clinical decision-making, patient outcomes, medical affairs, commercial life sciences, venture capital, health tech